NEW YORK (GenomeWeb News) – Quest Diagnostics this week announced a definitive agreement to buy full-service commercial laboratory firm Solstas Lab Partners for $570 million. Quest is buying Solstas from private equity firm Welsh, Carson, Anderson, and Stowe. Based in Greensboro, NC, Solstas operates in nine states in the Southeastern US. Quest said the deal is anticipated to add about 5 percent in annualized revenues and to be "modestly" accretive to adjusted EPS in 2014. The deal is expected to be completed in the first half of the year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.

In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.

An opinion piece at Bloomberg discusses China's stance on genomic research.

Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.